Thoracic Oncology

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today’s best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies. Offers practical, relevant coverage of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy. Provides authoritative guidance from the IASLC – the only global organization dedicated to the study of lung cancer. Includes new content on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer. Features a new full-color design throughout, as well as updated diagnostic algorithms.

In the United States alone, the incidence of new cases of thoracic neoplasms is over 180,000. Each year, over 170,000 individuals are expected to die of their cancer. Lung cancer is the most common of the thoracic neoplasms. It is the leading cause of cancer death in both men and women, accounting for 28% of all cancer deaths in the United States. Thoracic Oncology provides an up-to-date and concise review of the various thoracic neoplasms and offers a better understanding of the biology, natural history, diagnosis and treatment of these malignancies. This book will be of particular interest to clinicians interested in thoracic neoplasms, to better understand and treat them.

****When not purchasing directly from the official sales agents of the WHO, especially at online bookshops, please note that there have been issues with counterfeited copies. Buy only from known sellers and if there are quality issues, please contact the seller for a refund.***** Thoracic Tumoursis the fifth available volume in the fifth edition of the WHO series on the classification of human tumours. This series (also known as the WHO Blue Books) is regarded as the gold standard for the diagnosis of tumours and comprises a unique synthesis of histopathological diagnosis with digital and molecular pathology. These authoritative and concise reference books provide indispensable international standards for anyone involved in the care of patients with cancer or in cancer research, underpinning individual patient treatment as well as research into all aspects of cancer causation, prevention, therapy, and education. What's new in this edition? The fifth edition, guided by the WHO Classification of Tumours Editorial Board, establishes a single coherent cancer classification presented across a collection of individual volumes organized on the basis of anatomical site (digestive system, breast, soft tissue and bone, etc.) and structured in a systematic manner, with each tumour type listed within a taxonomic classification: site, category, family (class), type, and subtype. In each volume, the entities are now listed from benign to malignant and are described under an updated set of headings, including histopathology, diagnostic molecular pathology, staging, and easy-to-read essential and desirable diagnostic criteria. Who should read this book? * Pathologists * Oncologists * Respiratory physicians * Thoracic radiologists * Cancer researchers * Surgeons * Epidemiologists * Cancer registrars This volume: * Prepared by 217 authors and editors * Contributors from around the world * More than 1000 high-quality images * More than 3500 references

Global experts, in conjunction with the International Association for the Study of Lung Cancer, bring you up to date with today’s best approaches to lung cancer diagnosis, treatment, and follow-up. IASLC Thoracic Oncology, 2nd Edition, keeps you abreast of the entire scope of this fast-changing field, from epidemiology to diagnosis to treatment to advocacy. Written in a straightforward, practical style for the busy clinician, this comprehensive, multidisciplinary title is a must-have for anyone involved in the care of patients with lung cancer and other thoracic malignancies. Offers practical, relevant coverage of basic science, epidemiology, pulmonology, medical and radiation oncology, surgery, pathology, palliative care, nursing, and advocacy. Provides authoritative guidance from the IASLC – the only global organization dedicated to the study of lung cancer. Includes new content on molecular testing, immunotherapy, early detection, staging and the IASLC staging system, surgical resection for stage I and stage II lung cancer, and stem cells in lung cancer. Features a new full-color design throughout, as well as updated diagnostic algorithms.

Over the past nearly two decades, thoracic oncology has evolved into a highly complex oncologic subspecialty. Elaborate multimodality treatment regimens utilizing chemotherapy, radiation, surgery, and increasingly more complex biological agents, including targeted and immunologic therapies are now standard for a group of malignancies that themselves have become more complex due to increasingly detailed and discriminating staging and genetic evaluation standards. A rapidly advancing knowledgebase has led to dramatic improvements in individualized or "personalized" care; but the myriad of rapid changes also have created a challenge for oncologists to comprehend and incorporate into daily practice. This staggering rapidity of change highlights the need for a comprehensive thoracic oncology textbook designed to be frequently updated in order to keep clinicians, be they pulmonologists, pathologists, radiologists, surgeons, medical oncologists, radiation oncologists, or gastroenterologists, up-to-date in the most current care. Modern Thoracic Oncology utilizes a strategy designed to overcome the traditionally slow production timeline of textbook publication to keep abreast of the pace of change. To overcome this hurdle, we have recruited world experts, who have agreed to author a very small and concise topic (rather than a whole book chapter) so that the information can be frequently updated, reviewed, and published rapidly -- thereby keeping this book relevant and current. Whether one desires information regarding lung cancer screening, esophageal cancer staging, mutational analysis, targeted therapies, stereotactic ablative radiation with real-time imaging, minimally-invasive and robotic surgery, combination immunotherapy, microwave/cryoablation, or methods of early cancer detection, we have endeavored to encompass all of the latest information in the field of thoracic oncology. With frequent future updates, we hope that this ambitious reference textbook will become your sourcebook for thoracic oncology. Modern Thoracic Oncology is published in 3 volumes: Volume 1 entitled "General Principles of Thoracic Oncology" is a comprehensive introduction to thoracic oncology. Principles of thoracic oncology care are discussed and include topics, such as thoracic anatomy and embryology; medical evaluation of cancer patients, appropriate imaging modalities with a specific discussion of lung cancer screening, and the basic principles underlying the various treatment modalities. Under thoracic surgical oncology, details regarding the appropriate choice of staging as well as surgical resection of thoracic tumors are discussed with an emphasis on minimally-invasive and robotic surgery. In the radiation oncology section, treatment focusing on planning, specific types of radiation delivery, from conventional radiation to Intensity Modulated Radiation Therapy (IMRT) and Stereotactic Ablative Radiotherapy (SABR), and radiation-induced toxicities (and their management) are outlines in great detail. Basic tenets of precision medical oncology also are detailed including the genetic basis of 1st through 3rd line standard cytotoxic chemotherapy, targeted biological agents, and immunotherapy along with specific guidance regarding immune-related toxicities. The principles of other therapy options, including percutaneous image-guided ablative therapy and photodynamic therapy complete invasive options. Treatment of cancer patients does not stop at invasive therapies, however. Quality of life issues for patients and their families are discussed as well as topics such as nutrition, Chinese herbal medicine, pain management, acupuncture, and end of life care. Volume 2 entitled "Trachea, Lung, and Pleura" addresses lung cancer, one of the most common and deadliest malignancies in the world as well as two relatively rare respiratory tumors. The care of lung cancer patients is highly complex and inclu